한국연초학회지 (Journal of the Korean Society of Tobacco Science)

한국연초학회 (The Korean Society of Tobacco Science)
권호 표지

담배연기 노출량 평가 생체지표

Biomarkers of Exposure for Cigarette Smoke

  • 투고 : 2009.06.08
  • 발행 : 2009.06.25
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Biomarkers could be critical and useful tools for assessing the biological effects of smoking and detecting differences between potentially reduced exposure product (PREP) and conventional cigarettes. Smoking-related biomarkers can be classified into three categories as biomarkers of exposure, biomarkers of effects, and biomarkers of potential harm. When compared with the biomarkers of effects or harm, the biomarkers of exposure for chemical constituents of cigarette smoke are well established and characterized. In addition, they could offer the important information in understanding how cigarette smoke interacts with biological molecules and causes the disease to human. Therefore, we provide an overview of 6 biomarkers of exposure (Nicotine and nicotine metabolites, Carboxyhaemoglobin, NNAL (4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanol) and NNAL - glucuronide, 3-Hydroxypropyl-mercapturic acid, and Monohydroxy-butenyl-mercapturic acids, and Urine mutagenicity) which were validated through extensive research and clinical experience. These reliable biomarkers could help identify the efficacy of PREP by predicting early toxicological effects and lead to improve it.

키워드

참고문헌

  1. Athersuch, T. J., Keun, H., Tang, H. and Nicholson, J. K. (2006) Quantitative urinalysis of the mercapturic acid conjugates of allyl formate using high-resolution NMR spectroscopy. J Pharm Biomed Anal. 40(2): 410-416 https://doi.org/10.1016/j.jpba.2005.06.039
  2. Bowman, D. L., Smith, C. J., Bombick, B. R. and Avalos, J. T., Davis, R. A., Morgan, W. T. and Doolittle, D. J. (2002) Relationship between FTC 'tar' and urine mutagenicity in smokers of tobacco-burning or Eclipse cigarettes. Mutat Res. 521(1-2): 137-149 https://doi.org/10.1016/S1383-5718(02)00219-X
  3. Boeniger, M. F., Lowry, L. K, and Rosenberg, J. (1993) Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. Am Ind Hyg Assoc J. 54(10): 615-627 https://doi.org/10.1080/15298669391355134
  4. Byrd, G. D., Davis, R. A. and Ogden, M. W. (2005) A rapid LC-MS-MS method for the determination of nicotine and cotinine in serum and saliva samples from smokers: validation and comparison with a radioimmunoassay method. J Chromatogr Sci. 43(3): 133-140 https://doi.org/10.1093/chromsci/43.3.133
  5. Byrd, G. D. and Ogden, M. W. (2003) Liquid chromatographic/tandem mass spectrometric method for the determination of the tobacco-specific nitrosamine metabolite NNAL in smokers' urine. J Mass Spectrom. 38(1): 98-107 https://doi.org/10.1002/jms.406
  6. Carmella, S. G., Akerkar, S. and Hecht, S. S. (1993) Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan one in smokers' urine. Cancer Res. 53(4): 721-724
  7. Carmella, S. G., Akerkar, S. A., Richie, J. P. and Jr, Hecht, S. S. (1995) Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone (NNK) in smokers' urine. Cancer Epidemiol Biomarkers Prev. 4(6): 635-642
  8. Degiampietro, P., Peheim, E., Drew, D., Graf, H. and Colombo, J. P. (1987) Determination of thiocyanate in plasma and saliva without deproteinisation and its validation as a smoking parameter. J Clin Chem Clin Biochem. 25(10): 711-717
  9. Hatsukami, D. K., Benowitz, N. L., Rennard, S. I., Oncken, C. and Hecht, S. S. (2006) Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine Tob Res. 8(4): 600-622
  10. Hecht, S. S., Carmella, S. G., Murphy, S. E., Akerkar, S., Brunnemann, K. D. and Hoffmann, D. (1993) A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N Engl J Med. 329(21): 1543-1546 https://doi.org/10.1056/NEJM199311183292105
  11. Hecht, S. S. (1999) DNA adduct formation from tobacco-specific N-nitrosamines. Mutat Res. 424(1-2): 127-142 https://doi.org/10.1016/S0027-5107(99)00014-7
  12. Institute of Medicine, Committee on Quality of Health Care in America (2001). Crossing the quality chasm: A new health care system for the 21st century. National Academy Press, Washington, DC, USA
  13. International Agency for Research on Cancer (2007) Smokeless tobacco and tobacco-specific nitrosamines. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 89. Lyon (France): IARC; 2007. p. 553
  14. International Agency for Research on Cancer. (2004). Tobacco smoke and involuntary smoking. In, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. (Vol. 83). Lyon, France
  15. Jacob, P. 3rd,, Yu, L., Shulgin, A. T. and Benowitz, N. L. (1999) Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes. Am J Public Health. 89(5): 731-736 https://doi.org/10.2105/AJPH.89.5.731
  16. Kaye, C. M. (1973) Biosynthesis of mercapturic acids from allyl alcohol, allyl esters and acrolein. Biochem J. 134(4): 1093-1101 https://doi.org/10.1042/bj1341093
  17. Life Science Research Office (2007) Scientific methods to evaluate potential reduced-risk tobacco product, 1st ed. p.49-56, Catherine ed., Life Science Research Office, Maryland, USA
  18. McDonald, J. D., Bechtold, W. E., Krone, JR., Blackwell, W. B., Kracko, D. A. and Henderson, R. F. (2004) Analysis of butadiene urinary metabolites by liquid chromatography-triple quadrupole mass spectrometry. J Anal Toxicol. 28(3): 168-173 https://doi.org/10.1093/jat/28.3.168
  19. Muscat, J. E., Djordjevic, M. V., Colosimo, S., Stellman, S. D., and Richie, J. P. Jr. (2005) Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan one (NNK). Cancer. 103(7): 1420-1426 https://doi.org/10.1002/cncr.20953
  20. Roethig, H. J., Kinser, R. D., Lau, R. W., Walk, R. A. and Wang, N. (2005) Short-term exposure evaluation of adult smokers switching from conventional to first-generation electrically heated cigarettes during controlled smoking. J Clin Pharmacol. 45(2): 133-145 https://doi.org/10.1177/0091270004271253
  21. Sapkota, A., Halden, R. U., Dominici, F., Groopman, J. D. and Buckley, T. J. (2006) Urinary biomarkers of 1,3-butadiene in environmental settings using liquid chromatography isotope dilution tandem mass spectrometry. Chem Biol Interact. 160(1):70-79 https://doi.org/10.1016/j.cbi.2005.12.006
  22. Sepkovic, D. W. and Haley, N. J. (1985) Biomedical applications of cotinine quantitation in smoking related research. Am J Public Health. 75(6): 663-665 https://doi.org/10.2105/AJPH.75.6.663
  23. Scherer, G., Engl, J., Urban, M., Gilch, G., Janket, D. and Riedel, K. (2007) Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany. Regul. Toxicol. Pharmacol. 47(2); 171-183 https://doi.org/10.1016/j.yrtph.2006.09.001
  24. Scherer, G., Urban, M., Engl, J., Hagedorn, H. W. and Riedel, K. (2006) Influence of smoking charcoal filter tipped cigarettes on various biomarkers of exposure. Inhal Toxicol. 18(10): 821-829 https://doi.org/10.1080/08958370600747945
  25. Shields, P. G. (2002) Tobacco smoking, harm reduction, and biomarkers. J Natl Cancer Inst. 94(19): 1435-1444 https://doi.org/10.1093/jnci/94.19.1435
  26. SRNT Subcommittee on Biochemical Verification. (2002) Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 4(2): 149-159 https://doi.org/10.1080/14622200210123581
  27. Stevens, J. F. and Maier, C. S. (2008) Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol Nutr Food Res. 52(1): 7-25 https://doi.org/10.1002/mnfr.200700412
  28. Sturla, S. J., Scott, J., Lao, Y., Hecht, S. S. and Villalta, P. W. (2005) Mass spectrometric analysis of relative levels of pyridyloxobutylation adducts formed in the reaction of DNA with a chemically activated form of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan one. Chem Res Toxicol. 18(6): 1048-1055 https://doi.org/10.1021/tx050028u
  29. Tricker, A. R. (2006) Biomarkers derived from nicotine and its metabolites: a review, Beitr. Tabakforsch. Int. 22: 147–175
  30. Urban, M., Gilch, G., Schepers, G., van Miert, E. and Scherer, G. (2003) Determination of the major mercapturic acids of 1,3-butadiene in human and rat urine using liquid chromatography with tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 796(1): 131-140 https://doi.org/10.1016/j.jchromb.2003.08.009